Markets

Market Nav

INCOME STATEMENT

You can view the income statement for the last 5 years.

Indrayani Biotech Ltd.

May 21 BSE 57.95 (+ 1.04 1.83%)

Volume79614

Prev. Close
56.91

Open Price
56.91

Today's Low / High

56.91 59.75

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

46.80 99.70

Indrayani Biotech Ltd.is not traded in NSE

(₹ in Crs.)

Particulars	Mar 23	Mar 22	Mar 21	Mar 20	Mar 12
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	162.93	61.57	21.09	49.90	57.98
Total Operating Revenues	162.93	61.57	21.09	49.90	57.98

Other Income	4.49	0.22	0.27	0.20	0.20
Total Revenue	167.41	61.79	21.35	50.09	58.17

EXPENSES
Cost Of Materials Consumed	102.21	41.04	15.77	31.98	0.00
Purchase Of Stock-In Trade	0.00	0.00	0.00	0.50	0.00
Operating And Direct Expenses	0.00	0.00	0.00	0.00	55.89
Employee Benefit Expenses	23.54	10.22	5.94	11.35	0.69
Finance Costs	5.56	1.88	1.96	1.15	0.32
Depreciation And Amortisation Expenses	3.35	0.66	0.46	1.01	0.28
Other Expenses	19.95	3.54	4.33	3.29	0.97
Total Expenses	154.61	57.34	28.46	49.29	58.15

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	12.81	4.45	-7.11	0.81	0.03

Exceptional Items	-0.50	0.00	-4.11	0.00	0.00
Profit/Loss Before Tax	12.31	4.45	-11.22	0.81	0.03

Tax Expenses-Continued Operations
Current Tax	0.20	0.00	0.00	0.00	0.02
Deferred Tax	0.17	0.00	0.00	0.00	0.07
Total Tax Expenses	0.38	0.00	0.00	0.00	0.09
Profit/Loss After Tax And Before ExtraOrdinary Items	11.93	4.45	-11.22	0.81	-0.06

Profit/Loss From Continuing Operations	11.93	4.45	-11.22	0.81	-0.06

Profit/Loss For The Period	11.93	4.45	-11.22	0.81	-0.06

Minority Interest	-3.19	0.00	0.09	0.00	0.00
Share Of Profit/Loss Of Associates	0.00	-0.01	0.00	0.00	0.00
Consolidated Profit/Loss After MI And Associates	8.74	4.44	-11.12	0.81	-0.06

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	2.55	1.30	0.00	0.00	0.00
Diluted EPS (Rs.)	2.05	1.30	0.00	0.00	0.00

Particulars	Mar 23
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR
FaceValue	10.00

INCOME
Revenue From Operations [Net]	162.93
Total Operating Revenues	162.93
Other Income	4.49
Total Revenue	167.41
EXPENSES
Cost Of Materials Consumed	102.21
Purchase Of Stock-In Trade	0.00
Operating And Direct Expenses	0.00
Employee Benefit Expenses	23.54
Finance Costs	5.56
Depreciation And Amortisation Expenses	3.35
Other Expenses	19.95
Total Expenses	154.61
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	12.81
Exceptional Items	-0.50
Profit/Loss Before Tax	12.31
Tax Expenses-Continued Operations
Current Tax	0.20
Deferred Tax	0.17
Total Tax Expenses	0.38
Profit/Loss After Tax And Before ExtraOrdinary Items	11.93
Profit/Loss From Continuing Operations	11.93
Profit/Loss For The Period	11.93
Minority Interest	-3.19
Share Of Profit/Loss Of Associates	0.00
Consolidated Profit/Loss After MI And Associates	8.74
OTHER INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	2.55
Diluted EPS (Rs.)	2.05